Management Practicalities
Chair
Professor Giuseppe Saglio (Italy)
Co-chair
Professor Mohamed Yassin (Qatar)
Managing intolerances – Perspectives from the real world
Dr Massimo Breccia
Az. Policlinico Umberto I Sapienza University, Rome, Italy
Managing comorbidities – Hepatitis B reactivation
Dr Mohamed A Yassin
Senior Consultant Hematologist, NCCCR Associate Professor of Medicine, CMED-QU, Doha, Qatar
Managing comorbidities – Managing obesity
Dr Mohamed A Yassin
Senior Consultant Hematologist, NCCCR Associate Professor of Medicine, CMED-QU, Doha, Qatar
Managing Comorbidities – Association of Tuberculosis in Patients with CML
Dr Mohamed A Yassin
Senior Consultant Hematologist, NCCCR Associate Professor of Medicine, CMED-QU, Doha, Qatar
Managing comorbidities – Opthalmologic manifestations
Dr Mohamed A Yassin
Senior Consultant Hematologist, NCCCR Associate Professor of Medicine, CMED-QU, Doha, Qatar
TKI Interactions with Concomitant Medication
Dr Katerina Machova Polakova
Institute of Hematology and Blood Transfusion and 1st Faculty of Medicine, Charles University, Prague, Czech Republic
Nature and Incidence of Adverse Events
Dr Valentín García Gutiérrez
Department of Hematology and Hematherapy, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain
Generic TKIs - Giving your patient the most effective and safe usage
Dr Jeff Lipton
University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada
When to Consider Allogenic Transplantation in CML
Dr Jerry Radich
Clinical Research Division, Kurt Enslein Endowed Chair, Fred Hutch, Seattle, USA
When to consider allogenic transplantation in CML
Dr Guillermo J Ruiz Arguelles
Center for Hematology and Internal Medicine, Clinica Ruiz, Puebla, Mexico